View Clinical Trial (Medical Research Study)
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation - NCT00412984-19102(Clinical Trial 157756)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Philadelphia |
|
State:
|
|
PA |
| Zip Code: |
|
19102 |
| Conditions: |
|
Atrial Fibrillation - Atrial Flutter |
| Purpose: |
|
The trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner)
is as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in
subjects with atrial fibrillation and risk factors for stroke.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Males and females ≥ 18 yrs with AF and one or more of the following risk factors for
stroke:
- Age ≥ 75, previous stroke
- TIA or Systemic Embolism
- Symptomatic congestive heart failure or left ventricular dysfunction with LVEF ≤ 40%
- Diabetes mellitus or hypertension requiring pharmacological treatment |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|